Vistagen Therapeutics, Inc. SEC filings VTGN
Vistagen Therapeutics, Inc. has 908 filings in SEC EDGAR's recent list, going back to Sep 11, 2007. Its latest annual report, Form 10-K, was filed on Jun 15, 2026 for the period ended Mar 31, 2026. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 30, 2026 (exit or restructuring costs, other events). The company's fiscal year ends on March 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-K | Annual report | Jun 15, 2026 | Mar 31, 2026 |
| 10-K | Annual report | Jun 17, 2025 | Mar 31, 2025 |
| 10-K | Annual report | Jun 11, 2024 | Mar 31, 2024 |
| 10-K | Annual report | Jun 28, 2023 | Mar 31, 2023 |
| 10-K | Annual report | Jun 23, 2022 | Mar 31, 2022 |
| 10-K | Annual report | Jun 29, 2021 | Mar 31, 2021 |
| 10-K | Annual report | Jun 29, 2020 | Mar 31, 2020 |
| 10-K | Annual report | Jun 25, 2019 | Mar 31, 2019 |
| 10-K | Annual report | Jun 26, 2018 | Mar 31, 2018 |
| 10-K | Annual report | Jun 29, 2017 | Mar 31, 2017 |
| 10-K | Annual report | Jun 24, 2016 | Mar 31, 2016 |
| 10-K | Annual report | Jun 29, 2015 | Mar 31, 2015 |
| 10-K | Annual report | Jun 25, 2014 | Mar 31, 2014 |
| 10-K | Annual report | Jul 18, 2013 | Mar 31, 2013 |
| 10-K | Annual report | Jul 2, 2012 | Mar 31, 2012 |
| 10-K | Annual report | Mar 31, 2011 | Dec 31, 2010 |
| 10-K/A | Amended annual report | Aug 4, 2010 | Dec 31, 2009 |
| 10-K | Annual report | Mar 17, 2010 | Dec 31, 2009 |
| 10-K | Annual report | Mar 31, 2009 | Dec 31, 2008 |
Showing 19 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- VTGN (Nasdaq)
- Fiscal year ends
- March 31
- Incorporated in
- NV
- Headquarters
- South San Francisco, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1411685
- Former names
- Excaliber Enterprises, Ltd. (until Jun 8, 2011)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.